Loading
Exhibitor profile image for Aether Therapeutics
Aether is seeking to solve the global opioid crisis with a new medicine to treat pain and addiction by modulating a validated drug target with a novel mechanism.
Exhibitor profile image for AiVita Biomedical, Inc.
AIVITA Biomedical is a privately held company with a vaccine platform being applied in infectious disease and cancer. We also have assets in retinal degeneration and dermatology.
Exhibitor profile image for Allarity Therapeutics
Allarity Therapeutics is a clinical-stage precision medicine company actively advancing stenoparib, an orally available, small molecule inhibitor for patients with advanced recurrent ovarian cancer. T ...
Exhibitor profile image for AllerGene AI Therapeutics
AllerGene AI Therapeutics is a biotechnology company building first-in-class in vivo mRNA-LNP CAR-T therapies targeting disease-driving mast cells, with the potential to transform the treatment of mas ...
Exhibitor profile image for Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare sys ...
Exhibitor profile image for Alphyn Biologics, Inc.
Alphyn is developing a pipeline of unique multi-target topical therapeutics for dermatology. Our Platform is an impactful innovation because it has multiple bioactive compounds with multiple mechanism ...
Exhibitor profile image for Alzheimer's Drug Discovery Foundation
The Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the development of drugs to prevent, treat, and cure Alzheimer's disease. The ADDF is the only public charity solely focu ...
Exhibitor profile image for Archon Biosciences
Pioneering generative protein design (from the lab of 2024 Nobel Laureate, David Baker) delivers self-assembling, multi-valent/-specific Antibody Cages (AbCs - with 2-30 Ab), that are being developed ...
Exhibitor profile image for AROG Pharmaceuticals, Inc.
Arog is a late-stage, privately held U.S. biopharmaceutical company enrolling pivotal studies for crenolanib, an oral TKI with best-in-class profile for FLT3-mutated AML. Preliminary clinical data in ...
Exhibitor profile image for Aronora, Inc.
Aronora is a clinical-stage biopharmaceutical company pioneering innovative therapies for cardio-hematologic diseases with global unmet need.
437 Results